Journal of Molecular and Cellular Cardiology
Volume 44, Issue 3 , Pages 539-550 , March 2008

RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy

  • Xi Wang

      Affiliations

    • University of Washington, Department of Pathology, Seattle, Washington 98109, USA
    • Co-first authors.
    • ,
  • Lawrence D. Adams

      Affiliations

    • University of Washington, Department of Pathology, Seattle, Washington 98109, USA
    • Corresponding Author InformationCorresponding author. Department of Pathology, 815 Mercer Street, Rm. 419, Seattle, WA 98109-4714. Tel.: +1 206 543 7483; fax: +1 206 897 1540.
    • Co-first authors.
    • ,
  • Lil M. Pabón

      Affiliations

    • University of Washington, Department of Pathology, Seattle, Washington 98109, USA
    • ,
  • William M. Mahoney Jr.

      Affiliations

    • University of Washington, Department of Pathology, Seattle, Washington 98109, USA
    • ,
  • Diane Beaudry

      Affiliations

    • University of Montreal, Montreal, Quebec, Canada H2W 1T8
    • ,
  • Jagadambika Gunaje

      Affiliations

    • University of Washington, Department of Pathology, Seattle, Washington 98109, USA
    • ,
  • Randolph L. Geary

      Affiliations

    • Wake Forest University, Winston-Salem, North Carolina 27157, USA
    • ,
  • Denis deBlois

      Affiliations

    • University of Montreal, Montreal, Quebec, Canada H2W 1T8
    • ,
  • Stephen M. Schwartz

      Affiliations

    • University of Washington, Department of Pathology, Seattle, Washington 98109, USA

Received 16 July 2007 ,Revised 4 October 2007 ,Accepted 29 November 2007.

References 

  1. Adams LD, Geary RL, McManus B, Schwartz SM. A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ Res. Sep 29 2000;87(7):623–631
  2. Li J, Adams LD, Wang X, Pabon L, Schwartz SM, Sane DC, et al. Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque. J Vasc Surg. Sep 2004;40(3):519–528
  3. Hollinger S, Hepler JR. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol Rev. Sep 2002;54(3):527–559
  4. Cho H, Kozasa T, Bondjers C, Betsholtz C, Kehrl JH. Pericyte-specific expression of RGS5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J. Mar 2003;17(3):440–442
  5. Bondjers C, Kalen M, Hellstrom M, Scheidl SJ, Abramsson A, Renner O, et al. Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. Am J Pathol. Mar 2003;162(3):721–729
  6. Rogers JH, Tamirisa P, Kovacs A, Weinheimer C, Courtois M, Blumer KJ, et al. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Invest. Sep 1999;104(5):567–576
  7. Rogers JH, Tsirka A, Kovacs A, Blumer KJ, Dorn GW, Muslin AJ. RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice. J Mol Cell Cardiol. Feb 2001;33(2):209–218
  8. Schwartz SM, Geary RL, Adams LD. Vascular failure: a hypothesis. Curr Atheroscler Rep. May 2003;5(3):201–207
  9. Siderovski DP, Strockbine B, Behe CI. Whither goes the RGS proteins?. Crit Rev Biochem Mol Biol. 1999;34(4):215–251
  10. Dratz EA, Lewis JW, Schaechter LE, Parker KR, Kliger DS. Retinal rod GTPase turnover rate increases with concentration: a key to the control of visual excitation?. Biochem Biophys Res Commun. Jul 31 1987;146(2):379–386
  11. Vuong TM, Chabre M. Deactivation kinetics of the transduction cascade of vision. Proc Natl Acad Sci U S A. Nov 1 1991;88(21):9813–9817
  12. Ross EM, Wilkie TM. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem. 2000;69:795–827
  13. Bondjers C, Kalen M, Hellstrom M, Scheidl SJ, Abramsson A, Renner O, et al. Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. Am J Pathol. Mar 2003;162(3):721–729
  14. Chen C, Zheng B, Han J, Lin SC. Characterization of a novel mammalian RGS protein that binds to Galpha proteins and inhibits pheromone signaling in yeast. J Biol Chem. Mar 28 1997;272(13):8679–8685
  15. Zhou J, Moroi K, Nishiyama M, Usui H, Seki N, Ishida J, et al. Characterization of RGS5 in regulation of G protein-coupled receptor signaling. Life Sci. Feb 16 2001;68(13):1457–1469
  16. Chang YP, Liu X, Kim JD, Ikeda MA, Layton MR, Weder AB, et al. Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet. Feb 2007;80(2):253–264
  17. Denis CV, Wagner DD. Insights from von Willebrand disease animal models. Cell Mol Life Sci. Dec 1999;56(11–12):977–990
  18. Lemay J, Hou Y, deBlois D. Evidence that nitric oxide regulates AT1-receptor agonist and antagonist efficacy in rat injured carotid artery. J Cardiovasc Pharmacol. May 2000;35(5):693–699
  19. Seamon KB, Padgett W, Daly JW. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci U S A. Jun 1981;78(6):3363–3367
  20. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. Dec 2000;52(4):639–672
  21. Jalili T, Takeishi Y, Walsh RA. Signal transduction during cardiac hypertrophy: the role of G alpha q, PLC beta I, and PKC. Cardiovasc Res. Oct 1999;44(1):5–9
  22. Simonds WF. G protein regulation of adenylate cyclase. Trends Pharmacol Sci. Feb 1999;20(2):66–73
  23. Naga Prasad SV, Nienaber J, Rockman HA. Beta-adrenergic axis and heart disease. Trends Genet. Oct 2001;17(10):S44–S49
  24. Rockman HA, Koch WJ, Milano CA, Lefkowitz RJ. Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice. J Mol Med. Sep 1996;74(9):489–495
  25. Abramow-Newerly M, Roy AA, Nunn C, Chidiac P. RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell Signal. May 2006;18(5):579–591
  26. Heximer SP, Knutsen RH, Sun X, Kaltenbronn KM, Rhee MH, Peng N, et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest. Feb 15 2003;111(4):445–452
  27. Tang MK, Wang GR, Lu P, Karas RH, Aronovitz M, Heximer SP, et al. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med. Dec 2003;9(12):1506–1512
  28. Kirsch T, Wellner M, Luft FC, Haller H, Lippoldt A. Altered gene expression in cerebral capillaries of stroke-prone spontaneously hypertensive rats. Brain Res. Aug 10 2001;910(1–2):1106–1115
  29. Hubner N, Kreutz R, Takahashi S, Ganten D, Lindpaintner K. Altered angiotensinogen amino acid sequence and plasma angiotensin II levels in genetically hypertensive rats. A study on cause and effect. Hypertension. Aug 1995;26(2):279–284
  30. Wang Q, Liu M, Mullah B, Siderovski DP, Neubig RR. Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells. J Biol Chem. Jul 12 2002;277(28):24949–24958
  31. Li Y, Anand-Srivastava MB. Inactivation of enhanced expression of G(i) proteins by pertussis toxin attenuates the development of high blood pressure in spontaneously hypertensive rats. Circ Res. Aug 9 2002;91(3):247–254
  32. Marcil J, de Champlain J, nand-Srivastava MB. Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase. Cardiovasc Res. Aug 1998;39(2):492–505
  33. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. Apr 1982;62(2):347–504
  34. Tanski WJ, Roztocil E, Hemady EA, Williams JA, Davies MG. Role of Galphaq in smooth muscle cell proliferation. J Vasc Surg. Mar 2004;39(3):639–644
  35. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A. Jul 22 1997;94(15):8121–8126
  36. Cuq P, Zumbihl R, Fischer T, Rouot B, Bali JP, Magous R. Involvement of G alpha q/11 in the contractile signal transduction pathway of muscarinic M3 receptors in caecal smooth muscle. Eur J Pharmacol. Nov 14 1996;315(2):213–219
  37. Lee MJ, Tasaki T, Moroi K, An JY, Kimura S, Davydov IV, et al. RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. Proc Natl Acad Sci U S A. Oct 18 2005;102(42):15030–15035
  38. Kwon YT, Kashina AS, Davydov IV, Hu RG, An JY, Seo JW, et al. An essential role of N-terminal arginylation in cardiovascular development. Science. Jul 5 2002;297(5578):96–99
  39. Grant SL, Lassegue B, Griendling KK, Ushio-Fukai M, Lyons PR, Alexander RW. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Mol Pharmacol. Mar 2000;57(3):460–467
  40. Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott HP, et al. Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i). Circ Res. Oct 13 2000;87(8):705–709
  41. El-Armouche A, Zolk O, Rau T, Eschenhagen T. Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. Cardiovasc Res. Dec 1 2003;60(3):478–487
  42. Beilin LJ, Wade DN. Vascular hyper-reactivity with sodium loading and with deoxycorticosterone induced hypertension in the rat. Nature. Sep 12 1970;227(263):1141–1142
  43. Merkel LA, Bilder GE. Modulation of vascular reactivity by vasoactive peptides in aortic rings from hypercholesterolemic rabbits. Eur J Pharmacol. Nov 3 1992;222(1):175–179
  44. Wilson AJ. Vascular hyper-reactivity following arterial balloon injury: distant and delayed effects. Br J Pharmacol. May 2004;142(1):3–4
  45. Adams LD, Geary RL, Li J, Rossini A, Schwartz SM. Expression profiling identifies smooth muscle cell diversity within human intima and atherosclerotic plaque fibrous cap: loss of RGS5 distinguishes the cap SMC. Arterioscler Thromb Vasc Biol. Feb 2006;26(2):319–325

PII: S0022-2828(07)01323-5

doi: 10.1016/j.yjmcc.2007.11.019

Journal of Molecular and Cellular Cardiology
Volume 44, Issue 3 , Pages 539-550 , March 2008

Article Tools

* Image Usage & Resolution